alexa Kflc Index Evaluation to Assess Immunoglobulin Intrathecal Synthesis | OMICS International
ISSN: 2155-9899
Journal of Clinical & Cellular Immunology

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Kflc Index Evaluation to Assess Immunoglobulin Intrathecal Synthesis

Pieri M, Zenobi R and Dessi M*

Department of Experimental Medicine and Surgery, "Tor Vergata" University Hospital, Rome, Italy

*Corresponding Author:
Dessi M
Department of Experimental Medicine and Surgery
"Tor Vergata" University Hospital, Rome, Italy
Tel: +39-06-20902188
E-mail: [email protected]

Received date: June 22, 2017; Accepted date: August 02, 2017; Published date: August 06, 2017

Citation: Pieri M, Zenobi R, Dessi M (2017) Kflc Index Evaluation to Assess Immunoglobulin Intrathecal Synthesis. J Clin Cell Immunol 8:515. doi: 10.4172/2155-9899.1000515

Copyright: © 2017 Pieri M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Clinical & Cellular Immunology


Immunoglobulin; Multiple sclerosis (MS); kFLC Index


Intrathecal oligoclonal immunoglobulin synthesis is commonly observed In inflammatory disorders of the central nervous system (CNS) of either infectious or autoimmune origin [1,2].

Multiple sclerosis (MS), where intrathecal synthesis is present, is one of the most common neurological diseases of the young adults in CNS, and it often causes deficits since its early stage. Clinically isolated syndrome (CIS) is a central nervous system demyelinating event isolated in time and it is compatible with the possible future development of multiple sclerosis (MS). Early risk stratification for conversion to MS helps with treatment decisions [3]. Currently it is possible to identify the presence of antibodies by the detection of oligoclonal immunoglobulin bands (OCBs) in cerebrospinal fluid (CSF) [4,5]. It is necessary to differentiate the origin of immunoglobulin (Ig) in the CSF before intrathecal immunoglobulin synthesis can be diagnosed [6]. Immunoglobulin light chains that are circulating in serum in a free state are called Free Light Chains (FLCs). These can be both kappa (kFLCs) and lambda type (λFLCs). We examined 80 CSF/serum pairs from patients of the neurological clinic who underwent analysis of OCBs during their diagnostic workup. We analysed the correlation between OCBs test and the FLCs nephelometric assay [1] and we assessed the diagnostic accuracy of a nephelometric assay for k free light chain determination in cerebrospinal fluid and serum. The correlation between the two methods was very good, but the method to determine OCBs is time-consuming, not quantitative, and also relatively insensitive and operator depending. [1,2,7-9]. On the contrary, the nephelometric determination of FLCs in serum and CSF is a quantitative method and it might be a sensitive alternative to the above-mentioned approach.

In some cases we found positivity to intrathecal immunoglobulin synthesis with the nephelometric method, that was absent with immunofissation [1,9]. These results highlight the greater sensitivity and specificity of nephelometric assay method in the detection of intrathecal immunoglobulin synthesis [1,9-11]. The development and evaluation of new technologies to define local vs. systemic B-cell responses in patients with Multiple Sclerosis or Clinically Isolated Syndrome versus patients with other inflammatory neurological diseases should shed new light on the role of CSF OB [12]. The 80 patients studied were divided into three groups depending on the neurological diagnosis: non-inflammatory disorders (Group 1), inflammatory disorders excluding MS (Group 2) and patients with definitive MS (Group 3). The same patients were analyzed for the presence of immunoglobulins, FLCs and albumin on both serum and CSF to highlight possible differences between three groups.

During the study of the kFLCs (kappa Free Light Chains) concentration, we find that kFLC Index calculated as image provides a specific tool to follow intrathecal immunoglobulin synthesis and it seemed to be more accurate especially in patients with impaired CSF-serum barrier [1]. Furthermore kFLC Index, with the best sensitivity and specificity in MS patients, could replace the OCBs test and help the neurologists to monitor the patient’s treatment.

Subsequently [9], we have increased the number of patients in order to confirm our previous results. We analysed 176 patients and the results obtained confirmed the importance of the kFLC Index as an aid for the diagnosis of MS [9].

In the first study two patients had a CIS diagnosis (Group 2) but a kFLC Index higher than the cutoff (Figure 1A). Over time, these patients were again hospitalized and diagnosed with MS (Figure 1B, Group 3), highlighting kFLC Index's importance. One of these patients was followed in our hospital and he was the subject of a case report [13].


Figure 1: Scatter plot of three patient’s groups depending on neurological diagnosis, Group 1: non-inflammatory disorders; Group 2: inflammatory disorders excluding Multiple Sclerosis; Group 3: patients with definitive MS. (A) Scatter plot of all patients in the study of Duranti et al. 2013. (B) Scatter plot of all patients in the study Pieri et al. 2017. The arrow describe that two patients change their diagnosis during this time from clinically isolated syndrome to Multiple sclerosis, so they shift from Group 2 to Group 3. Our data indicates that the FLCs assay could replace the OCBs test and confirms the great specificity and sensitivity of the kFLC Index as a valid aid in the MS diagnosis. kFLC Index determination provides a tool for following changes in the synthesis of intrathecal immunoglobulins. Moreover its use in clinical routine, can assist the McDonald criteria facilitating a faster MS diagnosis and hence a more early therapeutic treatment. The kFLC Index is an early MS marker, and in some cases it may have a prognostic and predictive role in the diagnosis of MS.

Three patients within the 176 had a kFLC Index below the cutoff (Figure 1B) [9]; by studying these patients, we observed that they were undergoing therapy while all other patients were at their first diagnosis. These data may indicate a possible monitoring role of the kFLC Index during the patient’s therapy.

In conclusions, it would be desirable for neurologists to insert the kFLC Index determination in clinical routine to give a valid aid for the diagnosis and monitoring the patient's treatment.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 716
  • [From(publication date):
    August-2017 - Aug 17, 2018]
  • Breakdown by view type
  • HTML page views : 666
  • PDF downloads : 50

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A


[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


porn sex

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

Gaziantep Escort

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A


[email protected]

1-702-714-7001Extn: 9037


James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

mp3 indir

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals


Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T


[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version